COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?

Abstract

population, it is our experience that is not as catastrophic as we initially expected. Moreover, some of the observations made in the field of COVID-19-PAH/CTEPH have prompt the design of clinical trials that may allow us to broaden the knowledge of this disease and hopefully to improve its management.